Annual accounts
Audit Exemption Subsidiary accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
OVAL MEDICAL TECHNOLOGIES LIMITED
Active- 06810585Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 50/60 Station Road, Cambridge CB1 2JH
- Classification (SIC)
- Research and experimental development on social sciences and humanities (72.20 - SIC 2007)
- Accounts type
- Audit Exemption Subsidiary
Company activity
Every document filed at Companies House for this company.
Pre-Score for UK companies is coming soon
- 25/09/2026View PDF (17 pages)
Total exemption full accounts made up to 2025-12-31
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 05/02/2027
- Last statement dated
- 31/12/2024
Financial performance
The latest figures OVAL MEDICAL TECHNOLOGIES LIMITED filed. Okredo holds filed accounts data for 2021–2023; the year-by-year record is on the financials page.
Net Assets
£-411.24K2023
-114.35%vs 20222022: £2.87M
Total Assets
£3.64M2023
-15.07%vs 20222022: £4.29M
Cash in Bank
£216.83K2023
45.00%vs 20222022: £149.54K
Total Liabilities
£4.05M2023
184.95%vs 20222022: £1.42M
Employees
212023
-4vs 20222022: 25
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Net assets moved furthest, down 114.35% on 2022. See the full financial analysis for OVAL MEDICAL TECHNOLOGIES LIMITED.
The full financial record
Four ways through OVAL MEDICAL TECHNOLOGIES LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · -67% a year (CAGR)Three-year trend, 2021–2023Every measure end to end across 2021, 2022 and 2023, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2023.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 3 yearsEvery figure by yearAll 5 measures Okredo tracks across 3 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2023.
| Year | Employees | Change |
|---|---|---|
| 2023 | 21 | -4 |
| 2022 | 25 | -44 |
| 2021 | 69 | – |
Reported employee count decreased from 69 in 2021 to 21 in 2023. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
20Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 19/02/2010–23/01/2023 | 3 | |
| Corporate Secretary | 10/12/2016–Present | 58 | |
| Director | 19/02/2014–10/12/2016 | 3 | |
| Director | 19/02/2010–10/12/2016 | 8 | |
| Director | 19/02/2010–28/02/2015 | 9 | |
| Director | 01/07/2013–10/12/2016 | 9 | |
| Director | 16/04/2015–10/12/2016 | 7 | |
| Director | 16/06/2023–25/04/2025 | 10 | |
| Director | 19/02/2010–28/02/2015 | 4 | |
| Corporate Director | 29/12/2014–10/12/2016 | 22 | |
| Director | 15/09/2010–16/10/2013 | 28 | |
| Director | 10/12/2016–14/06/2023 | 6 | |
| Director | 15/12/2009–30/04/2013 | 10 | |
| Director | 10/12/2016–Present | 1 | |
| Director | 05/02/2009–23/01/2023 | 2 | |
| Director | 01/10/2013–10/12/2016 | 0 | |
| Director | 10/12/2016–Present | 2 | |
| Secretary | 23/11/2009–24/11/2010 | 0 | |
| Secretary | 24/11/2010–10/12/2016 | 0 | |
| Director | 16/11/2011–30/09/2013 | 0 |
Persons with significant control
1Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 10/12/2016–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 1 Since 25/09/2026
- Last 12 months
- 1
- Most recent filing
- 25/09/2026 less than a month ago
What changed in the last year
- Accounts filedLatest 25/09/2026
Filing timeline
- 25/09/2026View PDF (17 pages)
Total exemption full accounts made up to 2025-12-31
See when the next accounts and confirmation statement are due
Similar companies
34 UK companies are similar to OVAL MEDICAL TECHNOLOGIES LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on social sciences and humanities) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
CERES HOLOGRAPHICS LIMITED
ActiveSuite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh EH4 2HS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- SC330746
- Incorporated
- 11/09/2007
- Employees
- 22
WEATHERDEN LIMITED
Active264 Banbury Road, Oxford OX2 7DY
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09241011
- Incorporated
- 30/09/2014
- Employees
- 29
LIVER RESEARCH AND DEVELOPMENT LIMITED
Active111 Coldharbour Lane, London SE5 9NT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 07944232
- Incorporated
- 09/02/2012
- Employees
- 21
A.M.S. BIOTECHNOLOGY (EUROPE) LIMITED
ActiveMunro House Trafalgar Way, Bar Hill, Cambridge CB23 8SQ
- Activity
- Research and experimental development on biotechnology
- Company no.
- 02117791
- Incorporated
- 31/03/1987
- Employees
- 22
BIODIVERSIFY LTD
Active6 Great North Road, Cromwell, Newark, Nottinghamshire NG23 6JE
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11352631
- Incorporated
- 09/05/2018
- Employees
- 21
About OVAL MEDICAL TECHNOLOGIES LIMITED
A short description of the company, written from its Companies House record.
OVAL MEDICAL TECHNOLOGIES LIMITED is a private limited company registered in the United Kingdom, based in 50/60 Station Road, Cambridge CB1 2JH. Companies House classifies its business as Research and experimental development on social sciences and humanities. It has been on the register for 17 years 7 months.
The register currently records it as active. Its 2023 accounts report net assets of £-411.24K and 21 employees.
OVAL MEDICAL TECHNOLOGIES LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does OVAL MEDICAL TECHNOLOGIES LIMITED do?
Companies House records OVAL MEDICAL TECHNOLOGIES LIMITED under one registered business activity: Research and experimental development on social sciences and humanities (72.20 - SIC 2007).
Is OVAL MEDICAL TECHNOLOGIES LIMITED still active?
OVAL MEDICAL TECHNOLOGIES LIMITED is recorded as active on the Companies House register, and has been on it since 05/02/2009.
What are OVAL MEDICAL TECHNOLOGIES LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2023 and report net assets of £-411.24K, total assets of £3.64M, cash in bank of £216.83K and total liabilities of £4.05M.
When did OVAL MEDICAL TECHNOLOGIES LIMITED last file with Companies House?
The most recent document on the record is dated 25/09/2026: Total exemption full accounts made up to 2025-12-31, less than a month ago.
When are OVAL MEDICAL TECHNOLOGIES LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs OVAL MEDICAL TECHNOLOGIES LIMITED?
Companies House lists 20 officers (3 currently in post) and 1 person with significant control.